Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis.
Mette BøgelundAna Rosado IngelmoJose María Ausín RuizAdolfo Galán VivóHenrik BrandiMikkel Hasse PedersenAnne Sofie Ledgaard LoftagerMark AagrenPublished in: Clinical and translational allergy (2022)
Our study demonstrated that both adults with AR and caregivers of children with AR prefer daily SLIT-tablets to SCIT with either a weekly or monthly dose schedule.